Jamie L. Osman-Wager
Adult Medicine<quillbot-extension-portal></quillbot-extension-portal>
<p>Jamie Osman-Wager, MD, MPH, is an attending physician and Assistant Professor, Medicine at Montefiore Einstein. Her clinical focus centers on adult medicine.</p><p>After obtaining her Bachelor of Science from Cornell University in 2005, Dr. Osman-Wager completed a dietetic internship at NewYork-Presbyterian Hospital in 2006. She continued her medical education, earning her Master of Public Health at Harvard in 2010 and her Doctor of Medicine at Montefiore Einstein in 2011. She completed her internal medicine residency at New York University Langone Medical Center in 2014.</p><p>Dr. Osman-Wager’s research has been published in numerous peer-reviewed journals and presented at national conferences. She currently serves as site leader at Montefiore Einstein’s Moses campus for the third year medical student internal medicine clerkship. Most of her time focuses on educating and training residents and medical students.</p><p>Dr. Osman-Wager is board certified in Internal Medicine and is a member of the American Board of Internal Medicine and the Medical Society of the State of New York. In 2021, she won the Leo M. Davidoff Society Award for Excellence in the Teaching of Medical Students.</p>
Hauchie Pang
Adult Medicine<quillbot-extension-portal></quillbot-extension-portal>
Michele H. Mokrzycki
<p>Dr. Mokrzycki is a graduate of Boston College (B.S., 1983), and the University of Vermont College of Medicine (M.D., 1987) and received a Masters of Science in Clinical Research from the Albert Einstein College of Medicine (M.S. 2000). She completed both an Internal Medicine Residency and Clinical Nephrology Fellowship at the University of Connecticut Health Science Center in Farmington, CT. Dr Mokrzycki has been on faculty at the Albert Einstein College of Medicine since 1992, where she is a Professor of Medicine in the Division of Nephrology. She is a full time clinical nephrologist at the Montefiore Medical Center, Moses Campus.</p>
<p>Dr Mokrzycki's research interests have focused primarily on hemodialysis vascular access related complications, specifically, complications associated with tunneled catheter use such as infection/bacteremia/inflammation and dysfunction/thrombosis. </p>
<p>She is the recipient of a grant from the AETNA Foundation to study the effect of a multidisciplinary team approach to improve outcomes associated with catheter bacteremia in hemodialysis patients. </p>
<p>Dr Mokrzycki served on the Program Committee Member for the National Kidney Foundation (NKF) for 2 years, and on Faculty for the Therapeutic Apheresis Academy (TAA) for 5 years, which is held annually at the University of Virginia College of Medicine. She has been an invited speaker and/or chaired sessions at the American Society of Nephrology (ASN), National Kidney Foundation (NKF), the Vascular Access Society (VAS), Hemodialysis University (HDU), Annual Dialysis Conference (ADC), the American Society of Diagnostic and Interventional Nephrology (ASDIN), and the VEITH symposium.</p>
<p>Dr Mokrzycki served on the Catheter Endpoints Workgroup of the Kidney Health Initiative (KHI), formed by the American Society of Nephrology,the FDA and other stakeholders in End Stage Kidney Disease Innovation. Dr Mokrzycki currently serves as the Chair of the Vascular Accesss Outcomes Workgroup, a subgroup of the Nephrologists Transforming Dialysis Safety Initiative (NTDS), which is a collaboration between the American Society of Nephrology and the Centers for Disease Control. </p>
<p> </p>
<p>Dr. Mokrzycki is board certified in Nephrology and is a Fellow of the American Society of Nephrology. Clinical interests include Glomerular Diseases, Acute and Chronic Kidney Diseases, Hypertension, Kidney Stones, Renal Cystic Diseases, Dialysis, and Vascular Access for Hemodialysis.</p>
<p>Dr. Mokrzycki completed a Masters Program in Clinical Research at the Albert Einstein College of Medicine. The author of over 50 peer-reviewed publications, Dr. Mokrzycki’s research focuses on reducing hemodialysis vascular access infectious and thrombotic complications.</p>
<ol>
<li><strong>Mokrzycki MH</strong>, Yamase H, Kohn OF. Renal malacoplakia with papillary necrosis and renal failure. Am J Kidney Dis 19:587-91, 1992.</li>
<li><strong>Mokrzycki MH</strong>, Kaplan AA. Therapeutic Plasma Exchange: Complications and management. Am J Kidney Dis 23:817-27, 1994.</li>
<li><strong>Mokrzycki MH</strong>, Rickles F, Kaplan AA, Kohn OF. Thrombotic thrombocytopenic purpura in pregnancy: Successful treatment with plasma exchange. Blood Purif 13:271-82, 1995.</li>
<li>Posner L, <strong>Mokrzycki MH</strong>. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use. Am J Nephrol 16:339-43,1996.</li>
<li>Kerr A, Spector J, <strong>Mokrzycki MH</strong>, Blau S, Simon R. V asodilator provocation of occult urinar y tract hemorrhage. J Trauma 40:152-4, 1996.</li>
<li><strong>Mokrzycki MH</strong><span style="text-decoration: underline;">,</span> Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 7:1-5, 1996.</li>
<li><strong>Mokrzycki MH</strong><span style="text-decoration: underline;">,</span> Harris C, May H, Laut J, Palmisano J. Lactic acidosis associated with stavudine (d4T): Report of 5 cases. Clin Inf Dis 30:198-200, 2000.</li>
<li><strong>Mokrzycki MH</strong>, Schroppel B, von Gersdorff G, Rush H, Zdunek M, Feingold R. Tunneled cuffed catheter associated infections in hemodialysis patients seropositive for the human immunodeficiency virus. J Am Soc Nephrol 11:2122-2127, 2000.</li>
<li>Barisoni L, <strong>Mokrzycki MH</strong>, Sablay L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58:137-143, 2000.</li>
<li>Zdunek MP, Mitra A, <strong>Mokrzycki MH</strong>. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: Timing is important for maximizing clearance. Am J Kidney Dis 36:177-183, 2000.</li>
<li>Solomon N, <strong>Mokrzycki MH</strong>. Levofloxacin-associated allergic interstitial nephritis. Clin Nephrol 54:356, 2000.</li>
<li><strong>Mokrzycki MH</strong>, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 59:1935-1942, 2001.</li>
<li>Swiatecka-Urban A, <strong>Mokrzycki MH</strong>, Kaskel F, Da Silva F, Denamur E. Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome. Pediatr Nephrol 16:627-630, 2001.</li>
<li><strong>Mokrzycki MH,</strong> Singhal A. Cost-Effectiveness of Three Strategies of Managing Tunneled-Cuffed Hemodialysis Catheters (TCC) in Clinically Mild or Asymptomatic Bacteremias. Nephrol Dial Transpl 17(12): 2196-203, 2002.</li>
<li>Negulescu O, Coco M, Croll J, <strong>Mokrzycki MH</strong>. Large atrial thrombus formation associated with tunneled cuffed hemodialysis catheters. Clin Nephrol 59(1):40-6, 2003.</li>
<li>Golestaneh L, Laut J, Rosenberg S, Zhang M, <strong>Mokrzycki MH</strong>. Favourable outcomes in episodes of Pseudomonas bacteremia when associated with tunneled cuffed catheters (TCC) in chronic hemodialysis patients. Nephrol Dial Transplant. May;21(5):1328-33,2006.</li>
<li><strong>Mokrzycki MH</strong>, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunneled Hemodialysis Catheter Bacteremia: Risk factors for bacteremia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 21(4):1024-31,2006.</li>
<li><strong>Mokrzycki MH</strong>, Zhang M, Golestaneh L, Laut J, Rosenberg SO.A randomized controlled trial comparing two management models for the treatment of tunneled cuffed catheter (TCC) bacteremia: A collaborative team model versus usual physician-managed care. Am J Kidney Dis 48(4):587-95, 2006.</li>
<li>McKenzie LM, Hendrickson, SL, Briggs WA, Dart RA, Korbet SM, <strong>Mokrzycki MH</strong>, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA. NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol 18(11): 2987-95, 2007</li>
<li><strong>Mokrzycki MH.</strong> Use of prophylactic topical or intraluminal antibiotics for hemodialysis catheters. Nat Clin Pract Nephrol 4(9):478-9, 2008.</li>
<li>Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, <strong>Mokrzycki MH</strong>, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 40 (10):1175-84, 2008.</li>
<li>Sachdeva M, Bitzer M, <strong>Mokrzycki MH</strong>. Vascular access type and changes in inflammatory markers in incident dialysis patients: a pilot study. J Vascular Access 10(3):174-179, 2009.</li>
<li>Golestaneh L, Gofran A, <strong>Mokrzycki MH</strong>, Chen JL. Removal of vancomycin in sustained low-efficiency dialysis (SLED): a need for better surveillance and dosing. Clin Neph 72 (4):286-291.</li>
<li>Okafor C, Ward DM, <strong>Mokrzycki MH,</strong> Weinstein R, Clark P, Balogun RA. Introduciton and overview of therapeutic apheresis. J Clin Apheresis, 2010.</li>
<li>Lok CE, <strong>Mokrzycki MH</strong>. Advances in Hemodialysis Catheter-related Infection. U.S. Nephrol, 2010.</li>
<li><strong>Mokrzycki MH</strong>, Lok CE. Traditional and nontraditional strategies to optimize catheter function: <em>Go with more flow.</em> Kidney Int, 2010.</li>
<li>Lok CE, <strong>Mokrzycki MH</strong>. Update 2010: Catheter-related Infection in Hemodialysis Patients. Kidney Int. 2010.</li>
<li>Lok CE, <strong>Mokrzycki MH</strong>. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2010;79(6):587-98.</li>
<li><strong>Mokrzycki MH</strong>, Balogun RA. Therapeutic Apheresis: a review of complications and recommendations for prevention and management. J Clin Apher 2011:26(5):243-8.</li>
<li>Lee T, <strong>Mokrzycki MH</strong>, Moist L, Maya I, Vazquez M, Lok CE; North American Vascular Access Consortium. Standardized definitions for hemodialysis vascular access. Semin Dial 2011;24(5):515-24.</li>
<li>Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, <strong>Mokrzycki MH</strong>, Kimmel PL, Limous S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollack M, Winkler CA. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-Associated nephropathy. J Am Soc Nephrol 2011;22(11):2129-37.</li>
<li>Sachdeva M, Hung A, Kovalchuk O, Bitzer M, <strong>Mokrzycki MH</strong>. The initial vascular access type contributes to inflammation in incident hemodialysis patients. Int J Nephrol Volume 2012; (2012) Article ID: 917465.</li>
<li>Lee T, Lok C, Vazquez M, Moist L, Maya I, <strong>Mokrzycki M</strong>. Minimizing hemodialysis catheter dysfunction: An ounce of prevention. Int J Nephrol; Volume 2012 (2012), Article ID: 170857.</li>
<li>Golestaneh L, <strong>Mokrzycki MH</strong>. Vascular Access in Therapeutic Apheresis: Update 2013. J Clin Apheresis. 2013: 28(1):64-72.</li>
<li>Nica A, Lok CE, Harris J, Lee TC, <strong>Mokrzycki MH</strong>, Maya ID, Vazquez MA, Xi W, Moist LM; From the North American Vascular Access Consortium (NAVAC). Understanding Surgical Preference and Practice in Hemodialysis Vascular Access creation. Semin Dial. 2013:26(4):520-526.</li>
<li>Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 2014;370 (15):1393-1401.</li>
<li><strong>Mokrzycki MH</strong>, Lok CE. Optimizing central venous catheter primary prevention trials in hemodialysis patients. Am. J.Kidney Dis. 2015;66(6):939-941.</li>
<li>Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson P, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova , Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, <strong>Mokrzycki MH</strong>, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M. Complete remission in the nephrotic syndrome study network. Clin J Am Soc Nephrol. 2016;11 (1):81-89.</li>
<li>Johns, TS, <strong>Mokrzycki MH</strong>. Optimal approach for the diagnosis of hemodialysis catheter-related bacteremia. Clin J Am Soc Nephrol 2016; 11.</li>
<li>Liang E, Rodriguez M, Mueller M, Abramowitz MK, <strong>Mokrzycki MH</strong>. Outcomes Associated with a Heparin-Free Hemodialysis Protocol and Review of the Literature. J. Clin. Nephrol. Renal Care. 2016, 2(1): 10-16.</li>
<li>Allon M, Brouwer-Maier DJ, Abreo K, Baskin KM, Bregel K, Chand D, Easom A, Mermel L, <strong>Mokrzycki MH</strong>, Patel PR, Roy-Chaudhury P, Shenoy S, Valentini RP, Wasse H. Moving Points in Nephrology: Recommended Clinical Trial Endpoints for Hemodialysis Catheters. Clin J Am Soc Nephrol. 2017</li>
<li> Golestaneh L, <strong>Mokrzycki MH</strong>. Prevention of Hemodialysis Catheters Infections: Ointments, Dressings, Locks and Catheter Hub Devices. Hemodial Int. Nov 2018</li>
<li>Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabathou S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, <strong>Mokrzycki M</strong>, Rominieki H, Graham JA, Rocca JP, Bornkamp N, Jordan N, Schulte E, Wu M, Pullman J, Slowikowski K, Raychaudhuri S, Guthridge J, James J, Buyon J, Tuschl T, Putterman C; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019 Jul;20(7):915-927</li>
<li>Fisher M, Golestaneh L, Allon M, <span style="font-family: 'Times New Roman', serif; font-size: 12pt;"> </span><span style="font-family: 'Times New Roman', serif; font-size: 12pt;">Abreo K, </span><strong style="font-family: 'Times New Roman', serif; font-size: 12pt;">Mokrzycki MH. </strong>Preventing Central Vein Catheter Associated Bloodstream Infections in Hemodialysis: Review of Current Evidence-Based Strategies and Novel Therapies. <span style="font-size: 12pt; font-family: 'Times New Roman', serif;">Clin J Am Soc Nephrol 2020;15:132-151</span></li>
<li><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Vachharajani T , Wong L, Niyyar VD, Abreo KD, <strong>Mokrzycki MH</strong>, for the Vascular Access Workgroup of the Nephrologists Transforming Dialysis Safety Initiative of the American Society of Nephrology. Buttonhole cannulation of arteriovenous fistulas in the United States. Kidney360. 2020 </span></li>
<li><strong style="text-indent: -0.25in; font-family: 'Times New Roman', serif; font-size: 12pt;"><span style="font-size: 12pt;">Mokrzycki MH</span></strong><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;"> and Coco M. Management of hemodialysis patients with suspected or confirmed COVID-19 infection: perspective of two nephrologists in the United States. Kidney360. 2020:1(4);273-278.</span></li>
<li><span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;">Fisher M, Yunes M, <strong>Mokrzycki MH</strong>, Golestaneh L, Alahiri E, Coco M. “Chronic Hemodialysis Patients Hospitalized with COVID-19 – Short-term Outcomes in Bronx, New York”. Kidney360 June 2020</span>1.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></li>
<li><strong style="text-indent: -0.25in;"><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Mokrzycki MH</span></strong><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;">, Leigh KA, Kliger AS, Niyyar VD, Bren Asp V, Golestaneh L, Taylor Q, Novosad SA. Implementation of an Electronic Catheter Checklist in Outpatient Hemodialysis Facilities: Results of a Pilot Quality Improvement Project. Kidney360 April 2021, 2(4) 684-694</span>
<p class="MsoListParagraph" style="text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in;"> </p>
</li>
</ol>
<p><em><strong><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;">Book Chapter</span></strong></em></p>
<p class="MsoListParagraph" style="text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Times New Roman',serif;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 12.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Times New Roman',serif;">Fisher M, <strong style="mso-bidi-font-weight: normal;">Mokrzycki MH.</strong> Infectious complications in vascular access. Handbook of Dialysis. Nissenson: Handbook of Dialysis Therapy, 6e.</span> <span style="font-size: 12.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Times New Roman',serif;">Elsevir (In press, 2021)</span></p>
<p>Michele H. Mokrzycki, MD, MS, is an attending nephrologist and Professor, Medicine at Montefiore Einstein. Dr. Mokrzycki’s clinical interests include glomerular diseases, acute and chronic kidney diseases, hypertension, kidney stones, renal cystic diseases, dialysis and vascular access for hemodialysis.</p><p>After earning her Bachelor of Science from Boston College in 1983, Dr. Morkrzycki pursued her Doctor of Medicine at University of Vermont College of Medicine, earning the degree in 1987. She performed her postdoctoral training at University of Connecticut Health Center, completing her residency in internal medicine in 1990 and her fellowship in clinical nephrology in 1992. Dr. Mokrzycki later pursued additional education, completing her Master of Science in clinical research at Einstein in 2000.</p><p>Author of over 50 peer-reviewed publications, Dr. Mokrzycki’s research focuses on reducing hemodialysis vascular access infectious and thrombotic complications. She is on the editorial board for <em>Kidney360</em>, and is an invited reviewer for several publications including the <em>Journal of the American Society of Nephrology, Hemodialysis International</em> and the <em>Journal of Vascular Access.</em></p><p>Dr. Mokrzycki is board certified in Nephrology. She is a Fellow of the American Society of Nephrology and a member of several professional societies including the National Kidney Foundation, New York Society of Nephrology and the North American Vascular Access Consortium. In 2020, she was recognized as Reviewer of the Year by <em>Kidney360</em>.</p>
Rebecca A. Williams
<p><strong>Education</strong></p>
<p>Medical School: University of Illinois at Chicago (UIC)<br />Residency: University of Wisconsin, Appleton</p>
<p><strong>Professional Activity</strong></p>
<p>Dr. Rebecca Williams specializes in Family Medicine with concentrated practice in maternity care. She returned to UIC as residency faculty coordinating women’s health training. She completed a faculty development fellowship and a master's degree in health professions education. In 2004, she joined the Montefiore Einstein Department of Family and Social Medicine as residency faculty. She currently serves as the Director of Maternity Services for Family Medicine. After years as the sole attending family physician delivering babies at Montefiore hospitals, she now leads a team of family physicians providing care to a large group of women.</p>
<p>Dr. Williams holds an academic appointment in the Department of Family and Social Medicine. She is a member of the Society of Teachers of Family Medicine and teaches residents, students and fellows. She supervises training of residents on labor and delivery and in the office. She directs the Fellowship in Family Centered Maternity Care.</p>
<p>Dr. Williams's research interests are medical education and women’s health, with a focus on normal birth.</p>
Family Medicine
<ol>
<li>Schonberg, D and Williams, RA. Physical Activity in Pregnancy. What Should the Family Physician Recommend? Family Doctor. A Journal of the New York State Academy of Family Physicians. Winter 2013; 2(3):20-2.</li>
<li>NYMC Phelps Family Medicine Residency. AAFP Recommended Curriculum for Family Medicine Residency. Reprint 289C. Practice Based Learning and Improvement. Revised 7/2012.</li>
<li>Williams, RA. Women’s Health Content Validity of the Family Medicine In-training Examination. Family Medicine 2007;39:572-7.</li>
<li>Williams RA, Elam G: Gynecology in Rakel RE (Ed.): Textbook of Family Practice, Seventh Edition. Saunders, Philadelphia, 2007.</li>
<li>Williams RA: Breast-feeding in Rakel RE (Ed.): Saunders Manual of Medical Practice, Second Edition. Saunders, Philadelphia, 2000.</li>
<li>Hannon PR, Ehlert-Abler P, Aberman S, Williams RA, Carlos M. Commentary: A Multidisciplinary Approach to Promoting a Baby Friendly Environment in an Urban University Medical Center. Journal of Human Lactation 1999;15:289-296.</li>
</ol>
<p>Rebecca Williams, MD, MHPE , FAAFP, is Director, Maternity Services and Assistant Professor at Montefiore Einstein. Dr. Williams has more than three decades of experience as a family physician.</p><p>After completing her undergraduate education at the University of Illinois at Urbana-Champaign, Dr. Williams earned her Doctor of Medicine at the University of Illinois at Chicago. She began her postgraduate training in Wisconsin with an internship at Southeastern Family Practice, followed by a residency at Appleton Family Practice.</p><p>Dr. Williams is a Fellow of the American Academy of Family Physicians and a member of the Society of Teachers of Family Medicine.</p>
Kristen Welch
Adult Medicine<quillbot-extension-portal></quillbot-extension-portal>
Jeffrey M. Weiss
<p>Jeffrey Weiss, MD is a senior clinician-executive who has taken on progressive leadership positions at Montefiore Health System. Dr. Weiss earned a bachelor of science in industrial and labor relations from Cornell University, a medical degree from Stony Brook School of Medicine, and the Internal Medicine Residency Program at Montefiore, where he was chief resident.</p>
<p>In 2007, Dr. Weiss was named Institutional Medical Director for Montefiore Health System. His role is to help optimize the performance of the Montefiore health delivery network by ensuring a smooth interface between its various components - the doctors, hospital, medical group, home health agency, nursing homes, and the CMO. Dr. Weiss's responsibilities included leadership of nationally recognized patient safety, quality and peer review programs, management of a medical staff with 3,500 employed and voluntary physicians, supervision of GME activities for 1,200 residents in the second largest house staff program in the country, all under the coordinated umbrella of the "Office of the Medical Director" (OMD). As part of a restructuring of organizational clinical leadership in 2012, Dr. Weiss was named Vice President for Medical Affairs. In this role, he has retained many of his previous responsibilities, and is now leading a team of five newly appointed hospital medical directors in driving physician alignment and creating a horizontally integrated approach to quality and clinical performance across the system.</p>
<p>Dr. Weiss is an active clinician, teacher and researcher. He lectures nationally on topics including leadership, physician alignment, and patient safety in several forums, including as a faculty member for the AAMC and National Patient Safety Foundation.</p>
Adult Medicine<quillbot-extension-portal></quillbot-extension-portal>
Ryna Villar
<p><strong>Education</strong></p>
<p>Medical School: Warren Alpert Medical School of Brown University<br />Residency: New York Presbyterian Hospital</p>
<p><strong>Professional Activity</strong></p>
<p>Resident advising, medical student supervision, CQI, HIV CQI and care coordination resident teaching, inpatient medicine/resident supervision.</p>
Family Medicine
Andrew H. Telzak
Family Medicine
<p>Andrew Telzak, MD, MSc, is an attending physician and Director, New York City Research and Improvement Networking Group (NYC RING) at Montefiore Einstein and Assistant Professor, Family and Social Medicine and Pediatrics at our Albert Einstein College of Medicine. Dr. Telzak’s clinical focus is on providing comprehensive, high-quality primary care to families and communities. He has expertise in providing complex care coordination for patients with both medical and social needs.</p><p>After receiving his Bachelor of Arts in public health studies from The Johns Hopkins University in 2008, Dr. Telzak earned his Doctor of Medicine at Montefiore Einstein in 2016. He remained at this institution to complete his family medicine residency in 2019, where he was a Chief Resident in his final year. Following this, Dr. Telzak earned his Master of Science in clinical research methods at Montefiore Einstein in 2021 and completed a population health fellowship the same year.</p><p>Dr. Telzak’s research focuses on the intersection of social determinants of health and clinical outcomes for patients with chronic illnesses. He has been principal investigator and co-investigator on several grant-supported research projects and has shared his work through numerous peer-reviewed journals, abstracts, posters, book chapters and invited presentations. Dr. Telzak is also a reviewer for scientific journals, including <em>Circulation</em>, the <em>Journal of the American Heart Association</em>, <em>BMC Primary Care</em> and the <em>American Journal of Preventive Medicine</em>.</p><p>Dr. Telzak is board certified in Family Medicine. He is a member of the American Academy of Family Physicians and the North American Primary Care Research Group (NAPCRG).</p>
Ellen P. Tattelman
<p><strong>Education</strong></p>
<ul>
<li>Medical School: Yale University School of Medicine</li>
<li>Residency: Residency Program in Social Medicine/Family Medicine, Montefiore</li>
</ul>
<p><strong>Interests</strong></p>
<ul>
<li>Educational quality</li>
<li>Integrative medicine (complementary and alternative medicine)</li>
<li>Care of HIV + patients</li>
<li>Women’s health</li>
<li>Comfort with uncertainty</li>
<li>Maintaining our humanism in medicine</li>
</ul>
<p><strong>Expertise</strong></p>
<ul>
<li>Educational innovation</li>
<li>HIV and Hepatitis C primary care and QI</li>
<li>Integrative medicine</li>
<li>Healer's Art</li>
</ul>
<p><strong>Active Project</strong></p>
<ul>
<li>Ongoing HIV continuous quality improvement</li>
<li>Comfort with uncertainty</li>
<li>Teaching in the patient’s presence</li>
<li>The Healer’s Art</li>
<li>Healing Loss</li>
</ul>
<p><strong><br /></strong></p>
Family Medicine
<p><strong>Recent Publications and Presentations (selected)</strong></p>
<ul>
<li>Fallek R, <strong>Tattelman E</strong>, Browne T, Kaplan R, Selwyn P. Helping Providers and Staff Process Grief through a Hospital-Based Support Program. <a title="The American journal of nursing." href="https://www.ncbi.nlm.nih.gov/pubmed/?term=fallek+tattelman">Am J Nurs.</a> 2019 Jul;119(7):24-33. </li>
<li>Appelbaum, D, Kliger B, Barrett B, Frenkel M, Guerrera MP, Kondwani KA, Lee BB, <strong>Tattelman E</strong>. Natural and traditional medicine in Cuba: Lessons for U.S. medical education. Acad Med, 2006;81:1098-103.</li>
<li>Morrow R, <strong>Tattelman E</strong>, Purcell J, King J, Fordis, M. Academic Peer Detailing—The Preparation and Experience of Detailers Involved in a Project to Disseminate a Comparative Effectiveness Module. J Contin Educ Health Prof. 2016 Spring;36(2):123-6.</li>
<li><strong>Tattelman E</strong>, Purcell J, Morrow R. Academic Detailing: Train-the-Detailer Session. MedEdPORTAL Publications; 2015. Available from: <a href="https://www.mededportal.org/publication/10052" target="_blank">https://www.mededportal.org/publication/10052</a></li>
<li><strong>Tattelman E</strong>, Karnik A, Fornari A. Questioning as a Tool in Teaching. MedEdPORTAL; 2011. Available from: <span style="text-decoration: underline;"><a href="https://www.mededportal.org/publication/8419">www.mededportal.org/publi…;
<li><strong>RCT Comparing Patient, Intern and Faculty Experience with Teaching in the Patients’ Presence vs. in the Precepting Room. </strong>Oral Presentation on Completed Research, 47th North American Primary Care Research Group Annual Meeting, Toronto, Ontario, November 2019</li>
<li><strong>Teaching in the Patients’ Presence (TIPP): Intern, Faculty and Patient Experiences. </strong>Lecture-Discussion, Family Medicine Education Consortium, Northeast Regional Meeting, Lancaster Pennsylvania, November 2019 </li>
<li><strong>Empowering Family Medicine Residents to Deliver HIV Care in their Communities. </strong>Lecture-Discussion, Family Medicine Education Consortium, Northeast Regional Meeting, Lancaster Pennsylvania, November 2019 </li>
<li><strong>Dealing with Patients Whose Behavior is Racist. </strong>Workshop, Family Medicine Education Consortium, Northeast Regional Meeting, Lancaster Pennsylvania, November 2019 Seminar, Society of Teachers in Family Medicine, National Conference, Toronto, Ontario, April 2019</li>
<li><strong>Family Doctors as Specialist Consultants: What Does This Mean for Teaching Comprehensive Care of Our Patients. </strong>Seminar, Family Medicine Education Consortium, Northeast Regional Meeting, Rye Brook, NY, November 2018 </li>
<li><strong>Co-Location of Team Members in the Medical Home. </strong>Lecture-Discussion, Family Medicine Education Consortium, Northeast Regional Meeting, Rye Brook, NY, November 2018 </li>
</ul>